Items where Author is "Borchmann, Peter"

Article

Aleksandrova, Krasimira and Leise, Jana and Priesner, Christoph and Aktas, Murat and Apel, Michael and Assenmacher, Mario and Buerger, Iris and Richter, Anne and Altefrohne, Pia and Schubert, Christine and Holzinger, Astrid and Barden, Markus and Bezler, Valerie and von Bergwelt-Baildon, Michael and Borchmann, Peter and Goudeva, Lilia and Glienke, Wolfgang and Arseniev, Lubomir and Esser, Ruth and Abken, Hinrich and Koehl, Ulrike (2024) °Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma. FRONTIERS IN IMMUNOLOGY, 15: 1328368. ISSN 1664-3224,

Ernst, Moritz and Duehrsen, Ulrich and Hellwig, Dirk and Lenz, Georg and Skoetz, Nicole and Borchmann, Peter (2023) Diffuse Large B-Cell Lymphoma and Related Entities. DEUTSCHES ARZTEBLATT INTERNATIONAL, 120 (17). 289-+. ISSN 1866-0452,

Grund, Johanna and Iben, Katharina and Reinke, Sarah and Buehnen, Ina and Pluetschow, Annette and Mueller-Meinhard, Berit and Garcia Marquez, Maria A. and Schloesser, Hans A. and von Tresckow, Bastian and Kellermeier, Fabian and Borchmann, Peter and Engert, Andreas and Broeckelmann, Paul J. and Klapper, Wolfram (2023) Low B-cell content is associated with a CD73-low tumour microenvironment and unfavourable prognosis in classic Hodgkin lymphoma. BRITISH JOURNAL OF HAEMATOLOGY, 201 (6). pp. 1097-1102. ISSN 0007-1048, 1365-2141

Haanen, John B. A. G. and Mackensen, Andreas and Koenecke, Christian and Alsdorf, Winfried and Wagner-Drouet, Eva and Heudobler, Daniel and Borchmann, Peter and Bokemeyer, Carsten and Klobuch, Sebastian and Desuki, Alexander and Lueke, Florian and Wiegert, Erol and Schulz, Catrine and Rengstl, Benjamin and Preussner, Liane and Tuereci, Oezlem and Sahin, Ugur (2022) BNT211: A Phase I trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors. CANCER RESEARCH, 82 (12supp): CT002. ISSN 0008-5472, 1538-7445

Bethge, Wolfgang A. and Martus, Peter and Schmitt, Michael and Holtick, Udo and Subklewe, Marion and von Tresckow, Bastian and Ayuk, Francis and Wagner-Drouet, Eva Marie and Wulf, Gerald G. and Marks, Reinhard and Penack, Olaf and Schnetzke, Ulf and Koenecke, Christian and von Bonin, Malte and Stelljes, Matthias and Glass, Bertram and Baldus, Claudia D. and Vucinic, Vladan and Mougiakakos, Dimitrios and Topp, Max and Fante, Matthias A. and Schroers, Roland and Bayir, Lale and Borchmann, Peter and Buecklein, Veit and Hasenkamp, Justin and Hanoun, Christine and Thomas, Simone and Beelen, Dietrich W. and Lengerke, Claudia and Kroeger, Nicolaus and Dreger, Peter (2022) GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany. BLOOD, 140 (4). pp. 349-358. ISSN 0006-4971, 1528-0020

Jachimowicz, Ron D. and Klapper, Wolfram and Glehr, Gunther and Mueller, Horst and Haverkamp, Heinz and Thorns, Christoph and Hansmann, Martin Leo and Moeller, Peter and Stein, Harald and Rehberg, Thorsten and von Tresckow, Bastian and Reinhardt, H. C. and Borchmann, Peter and Chan, Fong Chun and Spang, Rainer and Scott, David W. and Engert, Andreas and Steidl, Christian and Altenbuchinger, Michael and Rosenwald, Andreas (2021) Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP. LEUKEMIA, 35 (12). pp. 3589-3593. ISSN 0887-6924, 1476-5551

Borchmann, Peter and Plutschow, Annette and Kobe, Carsten and Greil, Richard and Meissner, Julia and Topp, Max S. and Ostermann, Helmut and Dierlamm, Judith and Mohm, Johannes and Thiemer, Julia and Sokler, Martin and Kerkhoff, Andrea and Ahlborn, Miriam and Halbsguth, Teresa and Martin, Sonja and Keller, Ulrich and Balabanov, Stefan and Pabst, Thomas and Vogelhuber, Martin and Huttmann, Andreas and Wilhelm, Martin and Zijlstra, Josee M. and Moccia, Alden and Kuhnert, Georg and Brockelmann, Paul J. and von Tresckow, Bastian and Fuchs, Michael and Klimm, Beate and Rosenwald, Andreas and Eich, Hans and Baues, Christian and Marnitz, Simone and Hallek, Michael and Diehl, Volker and Dietlein, Markus and Engert, Andreas (2021) PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial. LANCET ONCOLOGY, 22 (2). pp. 223-234. ISSN 1470-2045, 1474-5488

Voltin, Conrad-Amadeus and Mettler, Jasmin and Grosse, Jirka and Dietlein, Markus and Baues, Christian and Schmitz, Christine and Borchmann, Peter and Kobe, Carsten and Hellwig, Dirk (2020) FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma-An Updated Overview. CANCERS, 12 (3): 601. ISSN 2072-6694

Boell, Boris and Pluetschow, Annette and Buerkle, Carolin and Atta, Johannes and Pfreundschuh, Michael and Feuring-Buske, Michaela and Vogelhuber, Martin and Soekler, Martin and Eichenauer, Dennis A. and Thielen, Indra and von Tresckow, Bastian and Fuchs, Michael and Engert, Andreas and Borchmann, Peter (2019) Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial. BRITISH JOURNAL OF HAEMATOLOGY, 185 (1). pp. 42-52. ISSN 0007-1048, 1365-2141

Fuchs, Michael and Goergen, Helen and Kobe, Carsten and Kuhnert, Georg and Lohri, Andreas and Greil, Richard and Sasse, Stephanie and Topp, Max S. and Schaefer, Erhardt and Hertenstein, Bernd and Soekler, Martin and Vogelhuber, Martin and Zijlstra, Josee M. and Keller, Ulrich Bernd and Krause, Stefan W. and Wilhelm, Martin and Maschmeyer, Georg and Thiemer, Julia and Duehrsen, Ulrich and Meissner, Julia and Viardot, Andreas and Eich, Hans and Baues, Christian and Diehl, Volker and Rosenwald, Andreas and von Tresckow, Bastian and Dietlein, Markus and Borchmann, Peter and Engert, Andreas (2019) Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. JOURNAL OF CLINICAL ONCOLOGY, 37 (31). 2835-+. ISSN 0732-183X, 1527-7755

Behringer, Karolin and Goergen, Helen and Hitz, Felicitas and Zijlstra, Josee M. and Greil, Richard and Markova, Jana and Sasse, Stephanie and Fuchs, Michael and Topp, Max S. and Soekler, Martin and Mathas, Stephan and Meissner, Julia and Wilhelm, Martin and Koch, Peter and Lindemann, Hans-Walter and Schalk, Enrico and Semrau, Robert and Kriz, Jan and Vieler, Tom and Bentz, Martin and Lange, Elisabeth and Mahlberg, Rolf and Hassler, Andre and Vogelhuber, Martin and Hahn, Dennis and Mezger, Joerg and Krause, Stefan W. and Skoetz, Nicole and Boell, Boris and von Tresckow, Bastian and Diehl, Volker and Hallek, Michael and Borchmann, Peter and Stein, Harald and Eich, Hans and Engert, Andreas (2015) Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial. LANCET, 385 (9976). pp. 1418-1427. ISSN 0140-6736, 1474-547X

Engert, Andreas and Haverkamp, Heinz and Kobe, Carsten and Markova, Jana and Renner, Christoph and Ho, Antony and Zijlstra, Josee and Kral, Zdenek and Fuchs, Michael and Hallek, Michael and Kanz, Lothar and Doehner, Hartmut and Doerken, Bernd and Engel, Nicole and Topp, Max and Klutmann, Susanne and Amthauer, Holger and Bockisch, Andreas and Kluge, Regine and Kratochwil, Clemens and Schober, Otmar and Greil, Richard and Andreesen, Reinhard and Kneba, Michael and Pfreundschuh, Michael and Stein, Harald and Eich, Hans Theodor and Mueller, Rolf-Peter and Dietlein, Markus and Borchmann, Peter and Diehl, Volker (2012) Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. LANCET, 379 (9828). pp. 1791-1799. ISSN 0140-6736

Engert, Andreas and Josting, Andreas and Haverkamp, Heinz and Villalobos, Matthias and Lohri, Andreas and Soekler, Martin and Zijlstra, Josee and Sturm, Isrid and Topp, Max S. and Rank, Andreas and Zenz, Thorsten and Vogelhuber, Martin and Nogova, Lucia and Borchmann, Peter and Fuchs, Michael and Flechtner, Hans-Henning and Diehl, Volker (2010) Epoetin Alfa in Patients With Advanced-Stage Hodgkin's Lymphoma: Results of the Randomized Placebo-Controlled GHSG HD15EPO Trial. JOURNAL OF CLINICAL ONCOLOGY, 28 (13). pp. 2239-2245. ISSN 0732-183X

Conference or Workshop Item

Mackensen, Andreas and Haanen, John B. A. G. and Koenecke, Christian and Alsdorf, Winfried and Wagner-Drouet, Eva Maria and Heudobler, Daniel and Borchmann, Peter and Bokemeyer, Carsten and Klobuch, Sebastian and Kutsch, Nadine and Mueller, Fabian and Desuki, Alexander and Lueke, Florian and Wiegert, Erol and Flemmig, Carina and Schulz-Eying, Catrine and Rengstl, Benjamin and Preussner, Liane and Tuereci, Oezlem and Sahin, Ugur (2023) CLDN6 CAR-T cell therapy of relapsed/refractory solid tumors ± a CLDN6-encoding mRNA vaccine: Dose escalation data from the BNT211-01 phase 1 trial using an automated product. In: Annual Meeting of the American Society of Clinical Oncology (ASCO), June 02-06, 2023, Chicago, IL.

Illerhaus, Gerald and Farreri, Andres J. M. and Binder, Mascha and Borchmann, Peter and Hasenkamp, Justin and Stilgenbauer, Stephan and Roeth, Alexander and Webern, Thomas and Egerer, Gerlinde and Ernst, Thomas and Hertenstein, Bernd and Lenz, Georg and Kobbe, Guido and Brunnberg, Uta and Schmidt, Christian and Kneba, Michael and Dreyling, Martin and Moehle, Robert and Panse, Jens and Heinicke, Thomas and Schroll, Sebastian and Larsen, Thomas S. and Salwender, Hans and Naumann, Ralph and Hess, Georg and Thurner, Lorenz and Pukrop, Tobias and Keller, Ulrich and Blystadt, Anne Kirsti and Kroschinsky, Frank P. and Re, Francesca and Pulczynski, Elisa and Orsucci, Lorella and Pospiech, Lisa and Deckert, Martina and Ponzoni, Maurilio and Wendler, Julia and Valk, Elke and Calimeri, Teresa and Kasenda, Benjamin and Trepel, Martin and Fricker, Heidi and von Gottberg, Philipp and Burger, Elvira and Ihorst, Gabriele and Grishina, Olga and Hader, Claudia and Zucca, Emanuele and Finke, Juergen and Schorb, Elisabeth (2022) Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43). In: 64th Annual Meeting and Exposition of the American Society of Hematology (ASH), December 10-13, 2022, New Orleans, LA.

Jacob, Anne Sophie and Fuchs, Michael and Kaul, Helen and Kobe, Carsten and Pabst, Thomas and Greil, Richard and Eichenauer, Dennis and Topp, Max and Just, Marianne and Hertenstein, Bernd and Schaub, Valdete and Vogelhuber, Martin and Zijlstra, Josee M. and Pluetschow, Annette and Baues, Christian and Rosenwald, Andreas and Dietlein, Markus and Borchmann, Peter and Engert, Andreas (2022) PET-Guided Treatment in Patients with Early-Stage Favorable Hodgkin Lymphoma: Follow-up Analysis of the HD16 Trial by the German Hodgkin Study Group. In: 35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin.

Mackensen, Andreas and Koenecke, Christian and Haanen, John and Alsdorf, Winfried and Desuki, Alexander and Wagner-Drouet, Eva and Heudobler, Daniel and Borchmann, Peter and Wiegert, Erol and Schulz, Catrine and Rengstl, Benjamin and Preussner, Liane and Tuereci, Oezlem and Sahin, Ugur (2021) BNT211: A PHASE I/II TRIAL TO EVALUATE SAFETY AND EFFICACY OF CLDN6 CAR-T CELLS AND VACCINE-MEDIATED IN VIVO EXPANSION IN PATIENTS WITH CLDN6-POSITIVE ADVANCED SOLID TUMORS. In: SITC 36th Anniversary Annual Meeting (SITC 2021), Nov. 12–14, 2021, Washington, D.C..

Other

Mackensen, Andreas and Haanen, John B. A. G. and Koenecke, Christian and Alsdorf, Winfried and Wagner-Drouet, Eva and Borchmann, Peter and Heudobler, Daniel and Ferstl, Barbara and Klobuch, Sebastian and Bokemeyer, Carsten and Desuki, Alexander and Lueke, Florian and Kutsch, Nadine and Mueller, Fabian and Smit, Eveline and Hillemanns, Peter and Karagiannis, Panagiotis and Wiegert, Erol and He, Ying and Ho, Thang and Kang-Fortner, Qing and Schlitter, Anna Melissa and Schulz-Eying, Catrine and Finlayson, Andrew and Flemmig, Carina and Kuehlcke, Klaus and Preussner, Liane and Rengstl, Benjamin and Tuereci, Oezlem and Sahin, Ugur (2023) CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial. NATURE PORTFOLIO, BERLIN.

Fuchs, Michael and Jacob, Anne Sophie and Kaul, Helen and Kobe, Carsten and Kuhnert, Georg and Pabst, Thomas and Greil, Richard and Broeckelmann, Paul J. and Topp, Max S. and Just, Marianne and Hertenstein, Bernd and Soekler, Martin and Vogelhuber, Martin and Zijlstra, Josee M. and Keller, Ulrich Bernd and Krause, Stefan W. and Duehrsen, Ulrich and Meissner, Julia and Viardot, Andreas and Eich, Hans-Theodor and Baues, Christian and Diehl, Volker and Rosenwald, Andreas and Buehnen, Ina and von Tresckow, Bastian and Dietlein, Markus and Borchmann, Peter and Engert, Andreas and Eichenauer, Dennis A. (2023) Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma. SPRINGERNATURE, LONDON.

Bishop, Michael and Flinn, Ian and Borchmann, Peter and Jaeger, Ulrich and Westin, Jason and Hamad, Nada and Purtill, Duncan and Greil, Richard and Thomas, Simone and Teshima, Takanori and Harigae, Hideo and Garcia, Carlos and Barba, Pere and Deol, Abhinav and Shaughnessy, Paul and Gu, Jessie and Andreola, Giovanna and Prieto, Marcela Martinez and Pacaud, Lida and Schuster, Stephen (2019) BELINDA : A phase 3 study evaluating the safety and efficacy of tisagenlecleucel versus standard of care in adult patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma. BMC, LONDON.